We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

216 hedge funds and large institutions have $3.72B invested in Maravai LifeSciences in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 92 increasing their positions, 76 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $6.21M | Put options by funds: $2.65M

21% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 76

2.41% more ownership

Funds ownership: 97.31% → 99.72% (+2.4%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less funds holding

Funds holding: 235 → 216 (-19)

17% less capital invested

Capital invested by funds: $4.51B → $3.72B (-$789M)

41% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 39

Holders
216
Holders Change
-19
Holders Change %
-8.09%
% of All Funds
3.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
92
Reduced
76
Closed
39
Calls
$6.21M
Puts
$2.65M
Net Calls
+$3.56M
Net Calls Change
-$7.32M

Top Buyers

Rank Fund Capital Flow
1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$118M
2
American Century Companies
American Century Companies
Missouri
+$75.9M
3
Renaissance Technologies
Renaissance Technologies
New York
+$30.5M
4
AIM
Artemis Investment Management
United Kingdom
+$29.1M
5
Prudential Financial
Prudential Financial
New Jersey
+$23.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$172M
2
CIP
Champlain Investment Partners
Vermont
-$36.8M
3
N
Natixis
France
-$35.3M
4
Millennium Management
Millennium Management
New York
-$17.6M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
151
Shell Asset Management
Netherlands
$315K +$120K +3,796 +52%
RC
152
RegentAtlantic Capital
New Jersey
$291K – – –
CIBC Asset Management
153
CIBC Asset Management
Ontario, Canada
$285K -$22.6K -714 -7%
CF
154
Cantor Fitzgerald
New York
$284K -$2.57M -81,000 -89%
CG
155
Caprock Group
Idaho
$283K +$6.91K +218 +2%
JAM
156
Jupiter Asset Management
United Kingdom
$280K +$312K +9,855 New
New York State Teachers Retirement System (NYSTRS)
157
New York State Teachers Retirement System (NYSTRS)
New York
$273K -$3.17K -100 -1%
Barclays
158
Barclays
United Kingdom
$268K +$143K +4,519 +92%
HF
159
HRT Financial
New York
$260K -$1.06M -33,371 -78%
DIA
160
Dana Investment Advisors
Wisconsin
$260K +$66.9K +2,112 +30%
AA
161
ALPS Advisors
Colorado
$255K -$2.95K -93 -1%
CB
162
Commerce Bank
Missouri
$240K – – –
MSAM
163
Moloney Securities Asset Management
Missouri
$237K -$63.4K -2,000 -19%
CAM
164
Connacht Asset Management
New York
$225K -$55.8K -1,760 -18%
MSRPS
165
Maryland State Retirement & Pension System
Maryland
$220K – – –
Mitsubishi UFJ Asset Management
166
Mitsubishi UFJ Asset Management
Japan
$216K -$27.3K -861 -10%
HFS
167
Hantz Financial Services
Michigan
$206K +$25.2K +795 +12%
PI
168
PineBridge Investments
New York
$205K +$229K +7,220 New
CG
169
Cutler Group
California
$197K -$22.2K -700 -9%
MIM
170
MetLife Investment Management
New Jersey
$193K -$9.31K -294 -4%
State of Tennessee, Department of Treasury
171
State of Tennessee, Department of Treasury
Tennessee
$170K -$74.3K -2,347 -28%
Deutsche Bank
172
Deutsche Bank
Germany
$166K +$38.9K +1,227 +27%
Simplex Trading
173
Simplex Trading
Illinois
$129K +$133K +4,193 +1,175%
APP
174
Alpha Paradigm Partners
Illinois
$119K +$132K +4,181 New
C
175
Covestor
United Kingdom
$108K +$105K +3,319 +700%
5 6
7
8 9

MRVI Hedge Fund Activity: Q2 2022 in Review

216 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q2 2022, worth a combined $3.72B — down 17% from $4.51B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of MRVI and 23 opened new positions — a net loss of 16 holders — while 76 trimmed existing stakes and 92 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $118M. The largest seller was Fidelity Investments, cutting an estimated $172M.

  • 216 institutional investors held Maravai LifeSciences (MRVI) as of Q2 2022, down from 235 in Q1 2022.
  • Funds reported $3.72B of Maravai LifeSciences stock for Q2 2022, down 17% quarter-over-quarter.
  • 23 funds opened new Maravai LifeSciences positions in Q2 2022 and 39 closed out, a net change of -16 holders.
  • The largest Maravai LifeSciences buyer in Q2 2022 was Massachusetts Financial Services, an estimated $118M added.
  • The largest Maravai LifeSciences seller in Q2 2022 was Fidelity Investments, an estimated $172M sold.

Based on aggregated 13F filings for Q2 2022.